Evidence map›Paper›PMID 41569728›Full record

ArticleJournal of neurosurgery. Case lessons2026

Distal noncontiguous recurrence and sarcomatous transformation of glioblastoma with stable molecular profile: illustrative case.

Jacob Howran, Kaytlin Andrews, Kana Ogawa, Douglas Cook, James Purzner, Fabio Ynoe Moraes, John P Rossiter, Teresa Purzner

Abstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jacob HowranSchool of Medicine, Queen's University, Kingston, Ontario, Canada.ORCID 0009-0001-4474-7806
Kaytlin AndrewsDepartment of Translational Medicine, Queen's University, Kingston, Ontario, Canada.ORCID 0009-0007-7673-3621
Kana OgawaDepartment of Translational Medicine, Queen's University, Kingston, Ontario, Canada.ORCID 0009-0005-2961-1862
Douglas CookSchool of Medicine, Queen's University, Kingston, Ontario, Canada.
James PurznerSchool of Medicine, Queen's University, Kingston, Ontario, Canada.ORCID 0009-0005-2397-9383
Fabio Ynoe MoraesSchool of Medicine, Queen's University, Kingston, Ontario, Canada.
John P RossiterSchool of Medicine, Queen's University, Kingston, Ontario, Canada.
Teresa PurznerSchool of Medicine, Queen's University, Kingston, Ontario, Canada.ORCID 0000-0002-5205-8568

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlioblastoma (GB) typically recurs locally and maintains a glial histopathological phenotype. Sarcomatoid transformation is rare, and distal extra-axial recurrence with bone and soft tissue involvement is exceptionally uncommon. Molecular features of such sarcomatoid transformations remain poorly described. OBSERVATIONS: The authors present the case of a 53-year-old man with a history of right temporal GB (IDH-wildtype, MGMT-unmethylated) treated with maximal safe resection and chemoradiotherapy. Eleven months postoperatively, surveillance MRI demonstrated local enhancement with a new left parasagittal extra-axial lesion with bony and subgaleal extension. Debulking and resection revealed a high-grade sarcomatoid tumor with focal glial immunophenotype, mimicking a secondary gliosarcoma but with near-complete predominance of the sarcomatous component. Molecular analysis demonstrated preservation of TERT, PIK3CA, and PTEN variants identified in the original GB, with acquisition of a TP53 mutation. LESSONS: This case illustrates a rare pattern of GB progression, characterized by distal extra-axial recurrence with sarcomatoid transformation. The shared driver TERT, PIK3CA, and PTEN mutations in the original right temporal and subsequent left extra-axial lesion support clonal evolution, while the newly acquired TP53 alteration may underlie histological shift. Clinicians should consider histological transformation when evaluating atypical or extracranial recurrences, as molecular continuity with the primary tumor can guide interpretation of tumor biology and recurrence patterns. https://thejns.org/doi/10.3171/CASE25714.

Indexed as

case reportdistal recurrenceglioblastomagliosarcomatransformation

Identifiers

PMID41569728
PMCPMC12770992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.